Capricor Says FDA Briefing Relies On Obsolete Analysis Plan Ahead Of Deramiocel Advisory Committee Meeting For Duchenne Muscular Dystrophy BLA

뉴스 본문을 불러오고 있어요.

Capricor Says FDA Briefing Relies On Obsolete Analysis Plan Ahead Of Deramiocel Advisory Committee Meeting For Duchenne Muscular Dystrophy BLA | 웨이프 WAPE

Capricor Says FDA Briefing Relies On Obsolete Analysis Plan Ahead Of Deramiocel Advisory Committee Meeting For Duchenne Muscular Dystrophy BLA

기사 요약

관련 종목

댓글 —